Status:
COMPLETED
Study Evaluating Effexor XR in Elderly Patients With Major Depression.
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Depression
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
Phase III study evaluating Effexor XR in elderly patients with major depression.
Eligibility Criteria
Inclusion
- Patients diagnosed with major depression based on DSM-IV-TR
- Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" of HAM-D at baseline
Exclusion
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00225485
Start Date
December 1 2003
Last Update
May 28 2007
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Ichikawa, Chiba, Japan, 272-0034
2
Ichikawa, Chiba, Japan, 272-0827
3
Kasuga, Fukuoka, Japan, 816-0801
4
Kitakyushu, Fukuoka, Japan, 802-8533